New Report: Review of U.S. Customs and Border Protection’s Fiscal Year 2022 Drug Control Budget Formulation

News from the Department of Homeland Security OIG
Having trouble viewing this email? View it as a Web page. Bookmark and Share

DHS Office of Inspector General - Newly Released Report

February 1, 2023                    Office of Public Affairs: dhs-oig.officepublicaffairs@oig.dhs.gov

Review of U.S. Customs and Border Protection’s Fiscal Year 2022 Drug Control Budget Formulation

Williams, Adley & Company – DC, LLP (Williams Adley), under contract with the Department of Homeland Security Office of Inspector General, issued an Independent Accountant’s Report on the U.S. Customs and Border Protection’s (CBP) FY 2022 Drug Control Budget Formulation Compliance Report. CBP management prepared the Budget Formulation Compliance Report and the related assertions to comply with the requirements of the ONDCP Circular, National Drug Control Program Agency Compliance Reviews, dated September 9, 2021.

Based on its review, nothing came to Williams Adley’s attention that caused it to believe that CBP’s FY 2022 Budget Formulation Compliance Report and related assertions are not presented in conformity with the criteria in the ONDCP Circular. Williams Adley did not make any recommendations as a result of its review.

Read Report No. OIG-23-11

U.S. DEPARTMENT OF HOMELAND SECURITY, OFFICE OF INSPECTOR GENERAL
WWW.OIG.DHS.GOV  l TWITTER: @DHSOIG